Structural Model of a Cyclic Dynorphin A Analog Bound to Dodecylphosphocholine Micelles by NMR and Restrained Molecular Dynamics
- 1 July 1997
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (14) , 2148-2155
- https://doi.org/10.1021/jm960562m
Abstract
The compound c[Cys5,11]dynorphin A-(1−11)-NH2, 1, is a cyclic dynorphin A analog that shows similar selectivity and potency at the κ-opioid receptor when compared to the native form of the peptide in central nervous system assays. Previous molecular mechanics calculations have shown that the ring portion of the isoform that is trans about the Arg9−Pro10 ω bond contains either a β-turn from residues Arg6 to Arg9 or an α-helical conformation. Our results from solution state NMR indicate that the compound exhibits cis−trans isomerism about the Arg9−Pro10 ω bond in both aqueous solution and when bound to dodecylphosphocholine micelles. Restrained molecular dynamics calculations show that the cis isoform of the peptide contains a type III β-turn from residues Arg7 to Pro10. Similar calculations on the trans isoform show it to contain a β-turn from residues Cys5 and Arg8. In this report we describe the generation of three-dimensional models from NMR data for the ring portions of both the cis and trans isoforms of 1 bound to dodecylphosphocholine micelles. Comparison with other dynorphin A structural information indicates that both the cis and trans isoforms of the peptide may be active as κ-opioid agonists.Keywords
This publication has 20 references indexed in Scilit:
- In search of the ‘bio‐active conformation’—Is it induced by the target cell membrane?Journal of Molecular Recognition, 1995
- Multiple Conformations and Proline cis-trans Isomerization in Salmon Calcitonin: A Combined Nuclear Magnetic Resonance, Distance Geometry, and Molecular Mechanics StudyBiochemistry, 1994
- Prediction of the conformational requirements for binding to the κ‐opioid receptor and its subtypes. I. Novel α‐helical cyclic peptides and their role in receptor selectivityBiopolymers, 1994
- New evidence for a membrane-bound pathway in hormone receptor bindingBiochemistry, 1993
- Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions 1, 6, 7, 8 and 10International Journal of Peptide and Protein Research, 1993
- Conformational and topographical considerations in the design of biologically active peptidesBiopolymers, 1993
- Preferred conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranesBiochemistry, 1985
- Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometryJournal of Molecular Biology, 1985
- Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteinsBiochemical and Biophysical Research Communications, 1983
- Conformational restrictions of biologically active peptides via amino acid side chain groupsLife Sciences, 1982